Skip to main content
. Author manuscript; available in PMC: 2013 Feb 28.
Published in final edited form as: Clin Pharmacol Ther. 2011 Feb 23;89(4):562–570. doi: 10.1038/clpt.2010.313

Figure 4.

Figure 4

Effect of CYP3A induction and inhibition on ALF miosis (dark-adapted pupil diameter change from baseline). Panels A and C show results for sequential IV and oral ALF administration; panels B and D show results for simultaneous IV and oral ALF dosing. Panels A and B show predicted miosis, based on the total ALF concentrations shown in Figure 3. Panels C and D show actual results.